Indole-based Novel Molecule as Preventive against COVID Variants
Recently, a team of researchers from India and Paris has developed a novel molecule that has shown promise in lab tests as a potential preventive against the variants of the SARS-CoV-2 virus.
Key Points
- The compounds are based on indole which are ubiquitous molecules found in some amino acids and natural alkaloids.
- The current molecules are designed to treat the acute and long-term symptoms of COVID-19.
- They are first in class molecules displaying the original property of targeting not only one but several molecular targets involved in COVID-19.
- Due to its multi-target properties, the compounds interfere with several stages of SARS-CoV-2 infection, including ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 India Approves First Dengue Vaccine
- 2 NeoSep1 Trial for Neonatal Sepsis
- 3 WHO Lists First Ebola BDBV Diagnostic Test
- 4 Mission Drishti Encounters Anomaly After Solar Storm
- 5 ISRO Conducts Gaganyaan IMAT-05 Test
- 6 India Launches Once-Weekly Basal Insulin
- 7 White Rabbit-Based Indian Standard Time Distribution Network
- 8 World's Largest Synchronized Spintronic Network Demonstrated
- 9 CeNS Develops Ultra-Sensitive Ammonia Sensor
- 10 MOF Material Removes Tritium Efficiently
